Classification
Product TypeProcessed Food
Product FormDietary supplement (oral dosage forms such as capsules/softgels/tablets)
Industry PositionConsumer health / food supplement product
Market
Vitamin E in Brazil is primarily marketed and consumed as a dietary supplement ("suplemento alimentar"), a food category regulated by ANVISA rather than a medicine category. Market access and on-pack communication are strongly shaped by ANVISA rules on permitted constituents, minimum/maximum daily amounts, labeling designation ("Suplemento Alimentar"), and authorized claims. Since 1 September 2024, ANVISA’s framework referenced in its public FAQ indicates that all dietary supplements must be notified to ANVISA, increasing the compliance burden and the consequences of documentation gaps. Enforcement actions publicized by ANVISA (including recalls and prohibitions) highlight practical risks around irregular manufacturing, labeling/claims, and traceability—especially for products sold via online channels.
Market RoleDomestic consumption market for vitamin E dietary supplements with active local manufacturing and import distribution; trade balance for vitamin E inputs is not stated in this record (data gap).
Domestic RoleRetail dietary supplement category governed by ANVISA composition, labeling, and claims rules.
Specification
Primary VarietyAlpha-tocopherol (Vitamin E) supplements; often provided as ester forms such as alpha-tocopheryl acetate to improve shelf life
Secondary Variety- Mixed tocopherols products (where marketed)
Physical Attributes- Fat-soluble antioxidant; finished products are commonly oil-based softgels or solid dosage forms (capsules/tablets) depending on formulation.
Compositional Metrics- Daily recommended intake on label must align with ANVISA minimum/maximum limits applicable to the target population group (per the supplement rules and their annexes/updates).
Packaging- Light- and oxygen-protective packaging is commonly used for antioxidant-sensitive formulations (e.g., opaque/amber containers and well-sealed packs), consistent with shelf-life protection practices for vitamin E forms used in supplements.
Supply Chain
Value Chain- Ingredient sourcing (vitamin E forms and excipients) → incoming QC and traceability records → blending/formulation → encapsulation/tableting → packaging and labeling in Portuguese → distribution (including online channels) → retail consumer
Temperature- Quality protection is typically focused on limiting oxidation (heat/light/oxygen exposure) and maintaining declared potency through shelf life; ANVISA rules reference stability studies as part of ensuring product characteristics through expiry.
Atmosphere Control- Oxygen exposure control is relevant for antioxidant-sensitive formulations (e.g., minimizing headspace oxygen and using tight seals where appropriate).
Shelf Life- Vitamin E in supplements and fortified foods is often esterified (e.g., acetate/succinate) to prolong shelf life while protecting antioxidant properties.
Freight IntensityLow
Transport ModeMultimodal
Risks
Regulatory Compliance HighNon-compliance with ANVISA’s dietary supplement framework (authorized constituents, minimum/maximum limits, required product designation, and restricted claims) and/or failures in required regularization (including the post-2024 notification requirements referenced by ANVISA) can result in import disruption, product prohibition, recall, and suspension of commercialization.Use a Brazil-specific regulatory checklist mapped to RDC 243/2018 and its companion instruments (including IN lists/updates) and confirm the correct regularization pathway (notification/registration) before shipment and market launch; perform pre-market label/claims legal review in Portuguese.
Counterfeit And Illicit Trade MediumOnline sales channels can amplify counterfeit or irregular lots, including cases where the responsible company does not recognize lots sold through marketplaces; this creates recall exposure and brand risk even for legitimate supply.Strengthen channel governance (authorized seller lists), implement lot-level authentication and post-market monitoring of online listings, and maintain rapid recall readiness with distributor cooperation.
Food Safety And Quality Systems MediumANVISA enforcement actions in the supplements sector highlight operational failures (BPF non-compliance, inadequate licensing, stability-study gaps, and traceability/label–composition divergence) that can trigger severe regulatory action.Audit contract manufacturers against BPF requirements (including ANVISA-aligned checklists), require stability study evidence supporting shelf life, and maintain documented traceability from raw material receipt to finished-lot release.
Labeling And Claims MediumTherapeutic/curative claims are prohibited for supplements and only authorized claims may be used under conditions tied to composition limits; misclaims can trigger enforcement and product suspension.Restrict on-pack and advertising language to ANVISA-authorized claims/wording for vitamin E and ensure the product meets the stated compositional conditions for those claims.
Sustainability- If vitamin E supply is sourced as natural tocopherols from vegetable-oil value chains, buyers may apply ESG due diligence on upstream agricultural feedstocks (e.g., deforestation-risk screening and traceability expectations for relevant oil crops).
Labor & Social- Risk of irregular/clandestine manufacturing and non-compliance with Good Manufacturing Practices for foods (BPF), including inadequate licensing, traceability failures, and missing stability studies, as evidenced by ANVISA enforcement actions in the supplements sector.
FAQ
Are vitamin E supplements considered medicines in Brazil?No. ANVISA’s public guidance states that dietary supplements (suplementos alimentares) are not medicines and therefore cannot claim to treat, prevent, or cure diseases; they are intended for healthy individuals to complement the diet with nutrients or other permitted constituents.
Can a vitamin E supplement in Brazil claim antioxidant benefits on the label?Yes, but only using ANVISA-authorized claims under the required compositional conditions. ANVISA’s IN 28/2018 includes an authorized vitamin E claim describing it as an antioxidant that helps protect against damage caused by free radicals, with use restricted to products that meet the applicable minimum limits (and related conditions) defined in the supplement framework.
Do dietary supplements need to be notified to ANVISA?ANVISA’s public FAQ indicates that, from 1 September 2024, new rules on food regularization require all dietary supplements to be notified to ANVISA, enabling broader consultation of regularized products.